AYSE ERTAMAY: Open Payments
NPI 1285821892 · JACKSON HEIGHTS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,148 in 60 payments from 14 companies in 2025. Trend: 2023 $1,078 · 2024 $1,134 · 2025 $2,148
Food & beverage: $2,148
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $704 |
| GENZYME CORPORATION | 8 | $525 |
| GlaxoSmithKline, LLC. | 19 | $274 |
| AstraZeneca Pharmaceuticals LP | 3 | $142 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $105 |
| Optinose US, Inc. | 3 | $69 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| Verona Pharma, Inc. | 1 | $27 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, ZERBAXA, NEFFY, TRELEGY ELLIPTA, Xhance, INSPIRE.
Industry payments across NY — which companies pay providers there.
